| Primary |
| Crohn's Disease |
38.5% |
| Acute Lymphocytic Leukaemia |
19.3% |
| Colitis Ulcerative |
13.5% |
| Acute Promyelocytic Leukaemia |
3.7% |
| Inflammatory Bowel Disease |
3.5% |
| B Precursor Type Acute Leukaemia |
3.3% |
| Acute Myelomonocytic Leukaemia |
2.4% |
| Lymphocytic Leukaemia |
1.8% |
| Colitis |
1.7% |
| Non-hodgkin's Lymphoma |
1.6% |
| B-cell Type Acute Leukaemia |
1.4% |
| Autoimmune Hepatitis |
1.3% |
| Colitis Microscopic |
1.3% |
| Malignant Histiocytosis |
1.3% |
| Acute Myeloid Leukaemia |
1.2% |
| T-cell Type Acute Leukaemia |
1.0% |
| Chemotherapy |
0.8% |
| Histiocytosis Haematophagic |
0.8% |
| Hepatosplenic T-cell Lymphoma |
0.7% |
| Psoriasis |
0.7% |
|
| Pancreatitis |
9.5% |
| Vomiting |
9.5% |
| Pancreatitis Acute |
8.9% |
| White Blood Cell Count Decreased |
8.4% |
| Hepatosplenic T-cell Lymphoma |
6.3% |
| Sepsis |
5.8% |
| B-cell Lymphoma |
5.3% |
| Pyrexia |
5.3% |
| Febrile Neutropenia |
4.7% |
| Non-hodgkin's Lymphoma |
4.2% |
| Acute Myeloid Leukaemia |
3.7% |
| Chromosome Abnormality |
3.7% |
| Hypoglycaemia |
3.7% |
| Thrombocytopenia |
3.7% |
| Hyperbilirubinaemia |
3.2% |
| Myelodysplastic Syndrome |
3.2% |
| Weight Decreased |
3.2% |
| Leukopenia |
2.6% |
| Lipase Increased |
2.6% |
| Lymphoma |
2.6% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
52.4% |
| Crohn's Disease |
10.2% |
| Product Used For Unknown Indication |
7.0% |
| Burkitt's Lymphoma |
4.7% |
| Acute Promyelocytic Leukaemia |
3.5% |
| T-cell Type Acute Leukaemia |
3.4% |
| Colitis Ulcerative |
3.3% |
| B Precursor Type Acute Leukaemia |
2.8% |
| Lymphocytic Leukaemia |
2.3% |
| Prophylaxis |
1.8% |
| Chemotherapy |
1.5% |
| Drug Use For Unknown Indication |
1.3% |
| Non-hodgkin's Lymphoma |
1.2% |
| Inflammatory Bowel Disease |
1.0% |
| Acute Myeloid Leukaemia |
1.0% |
| Pain |
0.7% |
| Immunosuppression |
0.6% |
| Ill-defined Disorder |
0.6% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Colitis |
0.4% |
|
| Osteonecrosis |
9.2% |
| Vomiting |
8.5% |
| Pyrexia |
8.2% |
| Sepsis |
7.3% |
| Hepatosplenic T-cell Lymphoma |
7.1% |
| Off Label Use |
6.2% |
| Renal Impairment |
5.5% |
| Pancreatitis |
5.3% |
| Post Transplant Lymphoproliferative Disorder |
5.1% |
| White Blood Cell Count Decreased |
4.8% |
| Neutropenia |
4.4% |
| Infection |
4.1% |
| Myelodysplastic Syndrome |
3.7% |
| Acute Myeloid Leukaemia |
3.2% |
| Glioma |
3.2% |
| Sinus Disorder |
3.2% |
| Multi-organ Failure |
3.0% |
| T-cell Lymphoma |
2.8% |
| Treatment Related Secondary Malignancy |
2.7% |
| Febrile Neutropenia |
2.5% |
|
| Concomitant |
| Crohn's Disease |
35.8% |
| Product Used For Unknown Indication |
24.5% |
| Drug Use For Unknown Indication |
12.0% |
| Colitis Ulcerative |
7.1% |
| Acute Lymphocytic Leukaemia |
3.7% |
| Inflammatory Bowel Disease |
2.1% |
| Pain |
1.7% |
| Vitamin Supplementation |
1.7% |
| Depression |
1.4% |
| Hypertension |
1.3% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Premedication |
1.1% |
| Prophylaxis |
1.0% |
| Colitis |
1.0% |
| Insomnia |
0.8% |
| Anxiety |
0.8% |
| Nausea |
0.7% |
| Mineral Supplementation |
0.7% |
| Diarrhoea |
0.7% |
| Supplementation Therapy |
0.6% |
|
| Crohn's Disease |
19.3% |
| Injection Site Pain |
11.2% |
| Vomiting |
8.4% |
| Drug Ineffective |
7.2% |
| Weight Decreased |
6.7% |
| Pyrexia |
5.2% |
| Incorrect Dose Administered |
4.4% |
| Nausea |
3.7% |
| Pain |
3.5% |
| Diarrhoea |
3.4% |
| Small Intestinal Obstruction |
3.3% |
| Headache |
3.1% |
| Pneumonia |
2.9% |
| Abdominal Pain |
2.8% |
| Fatigue |
2.8% |
| Colitis |
2.6% |
| Accidental Exposure |
2.5% |
| Colitis Ulcerative |
2.5% |
| Paraesthesia |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
|
| Interacting |
| Colitis Ulcerative |
43.0% |
| Contraception |
11.4% |
| Cough |
11.4% |
| Inflammatory Bowel Disease |
11.4% |
| Product Used For Unknown Indication |
8.8% |
| Supplementation Therapy |
7.0% |
| Vitamin Supplementation |
4.4% |
| Proctitis Ulcerative |
2.6% |
|
| Pruritus |
21.4% |
| Arthralgia |
14.3% |
| Oedema Mouth |
14.3% |
| Drug Interaction |
7.1% |
| Gastrointestinal Inflammation |
7.1% |
| Insomnia |
7.1% |
| Nephritis |
7.1% |
| Oropharyngeal Pain |
7.1% |
| Red Blood Cell Sedimentation Rate Increased |
7.1% |
| Stomatitis |
7.1% |
|
